{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:53:13Z","timestamp":1792626793938,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874442"],"award-info":[{"award-number":["81874442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ts201712096"],"award-info":[{"award-number":["ts201712096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111404","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:41:52Z","timestamp":1614645712000},"page":"111404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment"],"prefix":"10.1016","volume":"137","author":[{"given":"Zhangyang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111404_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2021.111404_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2019.00097","article-title":"Salvianolic acids: potential source of natural drugs for the treatment of fibrosis disease and cancer","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2021.111404_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MNH.0000000000000424","article-title":"Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response","volume":"27","author":"Strausser","year":"2018","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2021.111404_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111404_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jmig.2019.11.011","article-title":"Cellular components contributing to fibrosis in endometriosis: a literature review","volume":"27","author":"Vigan\u00f2","year":"2020","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.biopha.2021.111404_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2019.00202","article-title":"Tanshinones, critical pharmacological components in Salvia miltiorrhiza","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib8","first-page":"163","article-title":"Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology, Chin.","volume":"13","author":"Su","year":"2015","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2021.111404_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.apha.2019.10.001","article-title":"Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza","volume":"87","author":"Wang","year":"2020","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.biopha.2021.111404_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113285","article-title":"Anxiolytic effect of an extract of Salvia miltiorrhiza Bunge (Danshen) in mice","volume":"264","author":"Lin","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0091270005282630","article-title":"Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"45","author":"Zhou","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2007.01.004","article-title":"Cardiovascular effects of Danshen","volume":"121","author":"Cheng","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111404_bib14","first-page":"59","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"Meim","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fphar.2019.00850","article-title":"Tanshinone IIA exerts anti-inflammatory and immune-regulating effects on vulnerable atherosclerotic plaque partially via the TLR4\/MyD88\/NF-\u03baB signal pathway","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejphar.2016.09.041","article-title":"Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: possible role of silent information regulator 1","volume":"791","author":"Feng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2011.06.031","article-title":"Anti-angiogenic effect of tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2\/TIMP-2 secretion in vascular endothelial cells","volume":"310","author":"Tsai","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2021.111404_bib18","unstructured":"LesLaboratories Servier SAS, SMART Servier Medical Art, SMART Servier Med. Art. 2020. https:\/\/smart.servier.com\/%0Ahttps:\/\/smart.servier.com\/%0Ahttps:\/\/smart.servier.com\/category\/cellular-biology\/tissues\/page\/3\/."},{"key":"10.1016\/j.biopha.2021.111404_bib19","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S84035","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","author":"Chen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.111404_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/13543776.2013.736494","article-title":"Tanshinone derivatives: a patent review (January 2006 - September 2012)","volume":"23","author":"Tian","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2021.111404_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2015.03.002","article-title":"Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles","volume":"73","author":"Meng","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111404_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2014.11.008","article-title":"The cytokines of pulmonary fibrosis: much learned, much more to learn","volume":"74","author":"Luzina","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2021.111404_bib23","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111404_bib24","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.2147\/DDDT.S230572","article-title":"The protective role of tanshinone IIA in silicosis rat model via TGF-beta1\/Smad signaling suppression, NOX4 inhibition and Nrf2\/ARE signaling activation","volume":"13","author":"Feng","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2021.111404_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7309073","article-title":"Therapeutic potential of Salviae miltiorrhizae radix et rhizoma against human diseases based on activation of Nrf2-mediated antioxidant defense system: bioactive constituents and mechanism of action","volume":"2018","author":"Li","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2021.111404_bib26","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1089\/ars.2018.7569","article-title":"Tanshinone IIA activates nuclear factor-erythroid 2-related factor 2 to restrain pulmonary fibrosis via regulation of redox homeostasis and glutaminolysis","volume":"30","author":"An","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2021.111404_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7150\/ijms.8365","article-title":"Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2\/ angiotensin-(1-7) axis in rats","volume":"11","author":"Wu","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biopha.2021.111404_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109024","article-title":"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-\u03b21\/Smad signaling","volume":"319","author":"Feng","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2021.111404_bib29","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111404_bib30","first-page":"2955","article-title":"Tanshinone IIA attenuates paraquatinduced acute lung injury by modulating angiotensinconverting enzyme 2\/angiotensin(17) in rats","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111404_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109586","article-title":"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-\u03b21-Smad signaling pathway","volume":"121","author":"Feng","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111404_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jss.2015.02.062","article-title":"Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-beta-dependent epithelial to mesenchymal transition","volume":"197","author":"Tang","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111404_bib33","article-title":"The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy","volume":"9","author":"Rossini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111404_bib34","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.7150\/ijms.20396","article-title":"Tanshinone IIA inhibits beta-catenin nuclear translocation and IGF-2R activation via estrogen receptors to suppress angiotensin II-induced H9c2 cardiomyoblast cell apoptosis","volume":"14","author":"Chen","year":"2017","journal-title":"Int J. Med. Sci."},{"key":"10.1016\/j.biopha.2021.111404_bib35","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/jcmm.13557","article-title":"Tanshinone IIA prevents left ventricular remodelling via the TLR4\/MyD88\/NF-kappaB signalling pathway in rats with myocardial infarction","volume":"22","author":"Wu","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phymed.2010.06.002","article-title":"Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension","volume":"18","author":"Fang","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2021.111404_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexcr.2014.02.001","article-title":"Phytoestrogen, tanshinone IIA diminishes collagen deposition and stimulates new elastogenesis in cultures of human cardiac fibroblasts","volume":"323","author":"Mao","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2021.111404_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.intimp.2018.04.036","article-title":"Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase","volume":"60","author":"Huang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.31083\/ph.2011.0806","article-title":"Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats","volume":"66","author":"Wang","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.biopha.2021.111404_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jep.2012.10.044","article-title":"Hydrogen peroxide-mediated oxidative stress and collagen synthesis in cardiac fibroblasts: blockade by tanshinone IIA","volume":"145","author":"Wang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11596-012-1042-2","article-title":"Inhibitory effect of tanshinone II A on TGF II-beta1-induced cardiac fibrosis","volume":"32","author":"Zhou","year":"2012","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.biopha.2021.111404_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2155-8256(19)30011-0","article-title":"The growth and performance of nursing programs by ownership status","volume":"9","author":"Pittman","year":"2019","journal-title":"J. Nurs. Regul."},{"key":"10.1016\/j.biopha.2021.111404_bib43","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1159\/000495870","article-title":"Tanshinone IIA inhibits high glucose-induced collagen synthesis via nuclear factor erythroid 2-related factor 2 in cardiac fibroblasts","volume":"51","author":"Tsai","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.biopha.2021.111404_bib44","first-page":"1451","article-title":"Tanshinone IIA protects against cardiac fibrosis through inhibition of \u03b2-tubulin expression","volume":"32","author":"Zhang","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2021.111404_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/FJC.0000000000000214","article-title":"microRNA-29b mediates the antifibrotic effect of tanshinone IIA in postinfarct cardiac remodeling","volume":"65","author":"Yang","year":"2015","journal-title":"J. Cardiovasc. Pharm."},{"key":"10.1016\/j.biopha.2021.111404_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2021.111404_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2012.208","article-title":"Acute kidney injury and chronic kidney disease: an integrated clinical syndrome","volume":"82","author":"Chawla","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.111404_bib48","first-page":"1","article-title":"Tanshinone IIA attenuates renal fibrosis after acute kidney injury in a mouse model through inhibition of fibrocytes recruitment","volume":"2015","author":"Jiang","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2021.111404_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1142\/S0192415X16500403","article-title":"Tanshinone IIA protects against folic acid-induced acute kidney injury","volume":"44","author":"Jiang","year":"2016","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","article-title":"Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-beta\/Smad and NF-kappaB signaling pathway in 5\/6 nephrectomized rats","volume":"26","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib51","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.3892\/mmr.2017.6498","article-title":"Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis","volume":"15","author":"Cao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111404_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11596-008-0511-0","article-title":"Effects of tanshinone IIA on transforming growth factor beta1-Smads signal pathway in renal interstitial fibroblasts of rats","volume":"28","author":"Tang","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.biopha.2021.111404_bib53","doi-asserted-by":"crossref","first-page":"36698","DOI":"10.1038\/srep36698","article-title":"Rescue therapy with tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3\u03b2","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111404_bib54","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.3390\/molecules19068189","article-title":"Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice","volume":"19","author":"Lee","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111404_bib55","article-title":"Inhibitory effect of tanshinone IIA on rat hepatic stellate cells","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111404_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1742-7843.2009.00465.x","article-title":"Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells","volume":"106","author":"Che","year":"2010","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2021.111404_bib57","first-page":"1","article-title":"Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells","volume":"2012","author":"Pan","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib58","first-page":"1012","article-title":"Effect of tanshinone II on hepatic fibrosis in mice","volume":"29","author":"Sun","year":"2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.biopha.2021.111404_bib59","first-page":"31","article-title":"Effect of tanshinone IIA on CCl4-induced liver fibrosis in rats","volume":"25","author":"Liu","year":"2002","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.biopha.2021.111404_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rbmo.2016.11.006","article-title":"Progressive development of endometriosis and its hindrance by anti-platelet treatment in mice with induced endometriosis","volume":"34","author":"Zhang","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2021.111404_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.03.015","article-title":"Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation","volume":"428","author":"Zhang","year":"2016","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2021.111404_bib62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00404-015-3766-2","article-title":"Tanshinone IIA inhibits the proliferation, migration and invasion of ectopic endometrial stromal cells of adenomyosis via 14-3-3zeta downregulation","volume":"292","author":"Wan","year":"2015","journal-title":"Arch. Gynecol. Obs."},{"key":"10.1016\/j.biopha.2021.111404_bib63","first-page":"RA92","article-title":"Is abnormal eutopic endometrium the cause of endometriosis? The role of eutopic endometrium in pathogenesis of endometriosis","volume":"17","author":"Liu","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2021.111404_bib64","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.fertnstert.2011.06.034","article-title":"How can macroscopically normal peritoneum contribute to the pathogenesis of endometriosis?","volume":"96","author":"Fassbender","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biopha.2021.111404_bib65","doi-asserted-by":"crossref","DOI":"10.4314\/ajtcam.v9i3.2","article-title":"Extracts of Salvia miltiorrhiza bunge on the cytokines of rat endometriosis models","volume":"9","author":"Zhou","year":"2012","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-0034-1382877","article-title":"Prevention of experimental postoperative peritoneal adhesions through the intraperitoneal administration of tanshinone IIA","volume":"80","author":"Wang","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2021.111404_bib67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/0886022X.2011.623497","article-title":"Protection of tanshinone IIA to human peritoneal mesothelial cells (HPMC) through delaying cellular senescence induced by high glucose","volume":"34","author":"Cao","year":"2012","journal-title":"Ren. Fail"},{"key":"10.1016\/j.biopha.2021.111404_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/0886022X.2011.559681","article-title":"Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model","volume":"33","author":"Chunming","year":"2011","journal-title":"Ren. Fail"},{"key":"10.1016\/j.biopha.2021.111404_bib69","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.ASN.0000122826.40921.D7","article-title":"Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis","volume":"15","author":"Yung","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2021.111404_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.2003.00069.x","article-title":"Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients","volume":"64","author":"Zarrinkalam","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.111404_bib71","first-page":"24","article-title":"The role of fibrinolysis in adhesion formation","author":"Holmdahl","year":"1997","journal-title":"Eur. J. Surg. Suppl."},{"key":"10.1016\/j.biopha.2021.111404_bib72","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0735-1097(92)90344-M","article-title":"Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA\/u-PA chimera) in a combined arterial and venous thrombosis model in the dog","volume":"19","author":"Lu","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2021.111404_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.CIR.79.2.217","article-title":"Plasminogen activators. The old and the new","volume":"79","author":"Runge","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111404_bib74","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111404_bib75","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111404_bib76","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ophtha.2009.06.045","article-title":"Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration","volume":"116","author":"Bressler","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2021.111404_bib77","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/02713683.2017.1355467","article-title":"Tanshinone IIA inhibits VEGF secretion and HIF-1alpha expression in cultured human retinal pigment epithelial cells under hypoxia","volume":"42","author":"Alzhrani","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2021.111404_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2021.111404_bib79","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.3892\/mmr.2017.7743","article-title":"Tanshinone IIA inhibits high glucoseinduced proliferation, migration and vascularization of human retinal endothelial cells","volume":"16","author":"Fan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111404_bib80","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0891-5849(00)00223-9","article-title":"Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades","volume":"28","author":"Hubbard","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172419","article-title":"Tanshinone IIa protects retinal endothelial cells against mitochondrial fission induced by methylglyoxal through glyoxalase 1","volume":"857","author":"Qian","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib82","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2021.111404_bib83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2021.111404_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol."},{"key":"10.1016\/j.biopha.2021.111404_bib85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6061\/clinics\/2015(04)06","article-title":"Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway","volume":"70","author":"Liu","year":"2015","journal-title":"Clinics"},{"key":"10.1016\/j.biopha.2021.111404_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105968","article-title":"Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt\/mTOR\/p70S6K pathway in a murine model of systemic sclerosis","volume":"77","author":"Jiang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/SAP.0000000000000544","article-title":"Tanshinone IIA inhibits proliferation and induces apoptosis through the downregulation of survivin in keloid fibroblasts","volume":"76","author":"Chen","year":"2016","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.biopha.2021.111404_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105863","article-title":"Tanshinone IIA down-regulated p-Smad3 signaling to inhibit TGF-\u03b21-mediated fibroblast proliferation via lncRNA-HSRL\/SNX9","volume":"129","author":"Shi","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111404_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103461","article-title":"Sodium tanshinone IIA sulfonate attenuates silica-induced pulmonary fibrosis in rats via activation of the Nrf2 and thioredoxin system","volume":"80","author":"Zhu","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib90","article-title":"Sodium tanshinone IIA sulfonate stimulated Cl\u2212 secretion in mouse trachea","volume":"12","author":"Fehrenbach","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111404_bib91","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41598-017-18745-5","article-title":"Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111404_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173352","article-title":"Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process","volume":"883","author":"Jiang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6712585","article-title":"Sodium tanshinone IIA sulfonate prevents angiotensin II-induced differentiation of human atrial fibroblasts into myofibroblasts","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2021.111404_bib94","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3858\/emm.2009.41.7.056","article-title":"Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro","volume":"41","author":"Yang","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib95","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/10286020.2014.935769","article-title":"Sodium tanshinone IIA sulfonate attenuates radiation-induced fibrosis damage in cardiac fibroblasts","volume":"16","author":"Gu","year":"2014","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2021.111404_bib96","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3892\/ijmm.2015.2087","article-title":"Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-beta1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro","volume":"35","author":"Yang","year":"2015","journal-title":"Int J. Mol. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib97","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.fct.2009.03.038","article-title":"Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo","volume":"47","author":"Jiang","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2021.111404_bib98","first-page":"137","article-title":"[Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis]","volume":"25","author":"Niu","year":"2013","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"key":"10.1016\/j.biopha.2021.111404_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.rbmo.2020.04.006","article-title":"Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis","volume":"41","author":"Luo","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.biopha.2021.111404_bib100","first-page":"260","article-title":"Sodium tanshinone IIA sulfonate prevents postoperative peritoneal adhesions in rats by enhancing the activity of the peritoneal fibrinolytic system","volume":"36","author":"Lin","year":"2016","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.biopha.2021.111404_bib101","first-page":"294","article-title":"Effects of sodium tanshinone II A sulfonate on proliferation of fibroblasts in scar and the mRNA and protein expressions of transforming growth factor beta 1 and alpha smooth muscle actin","volume":"29","author":"Liu","year":"2013","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"10.1016\/j.biopha.2021.111404_bib102","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.intimp.2019.05.023","article-title":"Sodium tanshinone IIA sulfonate inhibits proliferation, migration, invasion and inflammation in rheumatoid arthritis fibroblast-like synoviocytes","volume":"73","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib103","article-title":"Sodium tanshinone IIA sulfonate ameliorates bladder fibrosis in a rat model of partial bladder outlet obstruction by inhibiting the TGF-\u03b2\/Smad pathway activation","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111404_bib104","doi-asserted-by":"crossref","first-page":"S707","DOI":"10.1080\/21691401.2018.1508028","article-title":"Nanoparticle-mediated delivery of tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-kappaB pathway","volume":"46","author":"Mao","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2021.111404_bib105","first-page":"3699","article-title":"Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro","volume":"10","author":"Qin","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.111404_bib106","first-page":"398","article-title":"Exploration method f ordetection of tanshinone\u2161A serum levelby HPlC chromatograms","volume":"31","author":"Yang","year":"2006","journal-title":"J. Chongqing Med. Univ."},{"key":"10.1016\/j.biopha.2021.111404_bib107","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S1872-2040(09)60010-4","article-title":"Determination of trace elements in plasma and brain of mice by HPLC tanshinone \u2161 A and its pharmacokinetics","volume":"36","author":"Gan","year":"2008","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.biopha.2021.111404_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108676","article-title":"Preventive and therapeutic role of tanshinone \u2161A in hepatology","volume":"112","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111404_bib109","first-page":"60","article-title":"Determination of tanshinone IIA in rat plasma by HPLC and its pharmacokinetics","volume":"13","author":"Wang","year":"2014","journal-title":"Tradit. Chin. Med. J."},{"key":"10.1016\/j.biopha.2021.111404_bib110","first-page":"368","article-title":"Determination of tanshinone IIA in rat plasma and the pharmacokinetics by RP-HPLC method","volume":"38","author":"Qiao","year":"2003","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2021.111404_bib111","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1248\/bpb.31.1469","article-title":"Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats","volume":"31","author":"Guo","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2021.111404_bib112","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpba.2010.03.041","article-title":"Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic-mass spectrometry and the application to pharmacokinetics in rats","volume":"53","author":"Liu","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2021.111404_bib113","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00498250902818335","article-title":"Hydroxylation of tanshinone IIa in human liver microsomes is specifically catalysed by cytochrome P4502A6","volume":"39","author":"Liu","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2021.111404_bib114","first-page":"882","article-title":"Metabolic kinetics of tanshinone\u2161A in rat liver microsomal enzyme","volume":"38","author":"Bi","year":"2007","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"10.1016\/j.biopha.2021.111404_bib115","first-page":"126","article-title":"Research progress on pharmacokinetics of tanshinone IIA","volume":"30","author":"Jiang","year":"2012","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib116","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/rcm.2367","article-title":"Simultaneous determination of tanshinone IIA and its three hydroxylated metabolites by liquid chromatography\/tandem mass spectrometry","volume":"20","author":"Li","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.biopha.2021.111404_bib117","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jms.1027","article-title":"Characterization of metabolites of tanshinone IIA in rats by liquid chromatography\/tandem mass spectrometry","volume":"41","author":"Li","year":"2006","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.biopha.2021.111404_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2018.04.011","article-title":"Inhibitory effects of Danshen components on CYP2C8 and CYP2J2","volume":"289","author":"Xu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2021.111404_bib119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jep.2016.01.021","article-title":"Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9","volume":"180","author":"Wang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2021.111404_bib120","series-title":"Influence of Tanshinone IIA on Cytochrome P450 Isoforms by Cocktail Approachin Rat Liver Microsomes In Vitro","author":"Liu","year":"2012"},{"key":"10.1016\/j.biopha.2021.111404_bib121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bdd.2213","article-title":"Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats","volume":"41","author":"Wang","year":"2020","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.biopha.2021.111404_bib122","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/bmc.778","article-title":"Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method","volume":"21","author":"Bi","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.biopha.2021.111404_bib123","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1055\/s-2006-951698","article-title":"Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion","volume":"72","author":"Hao","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2021.111404_bib124","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biomaterials.2012.10.017","article-title":"Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2021.111404_bib125","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/10837450.2019.1621897","article-title":"Preparation, optimization and cellular uptake study of tanshinone I nanoemulsion modified with lactoferrin for brain drug delivery","volume":"24","author":"Wu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.biopha.2021.111404_bib126","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/rcm.3080","article-title":"Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography\/multi-stage mass spectrometry with data-dependent acquisition","volume":"21","author":"Sun","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.biopha.2021.111404_bib127","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1248\/cpb.55.753","article-title":"Ion-pair reversed-phase HPLC method for determination of sodium tanshinone IIA sulfonate in biological samples and its pharmacokinetics and biodistribution in mice","volume":"55","author":"Mao","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.biopha.2021.111404_bib128","first-page":"660","article-title":"Study of sodium tanshinone II A sulfonate tissue distribution in rat by liquid chromatography\/tandem mass spectrometry","volume":"60","author":"He","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopha.2021.111404_bib129","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/00498250902951763","article-title":"Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers","volume":"39","author":"Chen","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2021.111404_bib130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13020-016-0083-z","article-title":"Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro","volume":"11","author":"Ouyang","year":"2016","journal-title":"Chin. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib131","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3109\/00498254.2016.1152417","article-title":"Sodium tanshinone IIA sulfonate and its interactions with human CYP450s","volume":"46","author":"Chen","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2021.111404_bib132","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA Wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib133","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2019.04.001","article-title":"LncRNA: shedding light on mechanisms and opportunities in fibrosis and aging","volume":"52","author":"Yang","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2021.111404_bib134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","article-title":"siRNA- and miRNA-based therapeutics for liver fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2021.111404_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109617","article-title":"WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-\u03b21\/Smads signaling","volume":"121","author":"Ma","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2021.111404_bib136","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41416-018-0267-7","article-title":"Statins attenuate outgrowth of breast cancer metastases","volume":"119","author":"Beckwitt","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2021.111404_bib137","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/molecules24142584","article-title":"Rapid identification of tanshinone IIA metabolites in an amyloid-\u03b2(1-42) induced Alzherimer\u2019s disease rat model using UHPLC-Q-exactive qrbitrap mass spectrometry","volume":"24","author":"Liang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111404_bib138","first-page":"174","article-title":"Metabolites of tanshinone \u2160 and tanshinone \u2161 a in rats","volume":"43","author":"Zhao","year":"2018","journal-title":"J. Chin. Tradit. Med."},{"key":"10.1016\/j.biopha.2021.111404_bib139","first-page":"218","article-title":"Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis","volume":"17","author":"Qin","year":"2019","journal-title":"Chin. J. Nat. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:37:32Z","timestamp":1778693852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":139,"alternative-id":["S075333222100189X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111404","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111404"}}